Effects of Cannabis Legalization on Adolescent Cannabis Use Across 3 Studies
This originally appeared at https://www.ajpmonline.org/article/S0749-3797(22)00491-3/fulltext#.Y5ZgZyDF40U.linkedin
- Jennifer A. Bailey, PhD
- Stacey S. Tiberio, PhD
- David C.R. Kerr, PhD
- Marina Epstein, PhD
- Kimberly L. Henry, PhD
- Deborah M. Capaldi, PhD
Published:November 10, 2022DOI:https://doi.org/10.1016/j.amepre.2022.09.019
Introduction
Canada, Uruguay, and 18 states in the U.S. have legalized the use of nonmedical (recreational) cannabis for adults, yet the impact of legalization on adolescent cannabis use remains unclear. This study examined whether cannabis legalization for adults predicted changes in the probability of cannabis use among adolescents aged 13–18 years.
Methods
Data were drawn from 3 longitudinal studies of youth (spanning 1999–2020) centered in 3 U.S. states: Oregon, New York, and Washington. During this time, Oregon (2015) and Washington (2012) passed cannabis legalization; New York did not. In each study, youth average age was 15 years (total N=940; 49%–56% female, 11%–81% Black/African American and/or Latinx). Multilevel modeling (in 2021) of repeated measures tested whether legalization predicted within- or between-person change in past-year cannabis use or use frequency over time.
Results
Change in legalization status across adolescence was not significantly related to within-person change in the probability or frequency of self-reported past-year cannabis use. At the between-person level, youth who spent more of their adolescence under legalization were no more or less likely to have used cannabis at age 15 years than adolescents who spent little or no time under legalization.
Conclusions
This study addresses several limitations of repeated cross-sectional studies of the impact of cannabis legalization on adolescent cannabis use. Findings are not consistent with changes in the prevalence or frequency of adolescent cannabis use after legalization. Ongoing surveillance and analyses of subpopulations are recommended.
REFERENCES
- Hawkins JD
- Catalano RF
- Miller JY.
- Blest-Hopley G
- O'Neill A
- Wilson R
- Giampietro V
- Bhattacharyya S
- Volkow ND
- Swanson JM
- Evins AE
- et al.
- Guttmannova K
- Kosterman R
- White HR
- et al.
- Cerdá M
- Mauro C
- Hamilton A
- et al.
- Hammond D
- Goodman S
- Wadsworth E
- Rynard V
- Boudreau C
- Hall W.
- Borodovsky JT
- Lee DC
- Crosier BS
- Gabrielli JL
- Sargent JD
- Budney AJ.U.S.
- Epstein M
- Bailey JA
- Kosterman R
- Furlong M
- Hill KG.
- Hall W.
- Pacula RL.
- Coley RL
- Hawkins SS
- Ghiani M
- Kruzik C
- Baum CF.
- Zuckermann AME
- Battista KV
- Bélanger RE
- et al.
- Rotermann M.
- Paschall MJ
- García-Ramírez G
- Grube JW.
- Dilley JA
- Richardson SM
- Kilmer B
- Pacula RL
- Segawa MB
- Cerdá M.
- Shadish WR
- Cook TD
- Campbell DT.
- Smart R
- Pacula RL.
- Rusby JC
- Westling E
- Crowley R
- Light JM.
- Bailey JA
- Epstein M
- Roscoe JN
- Oesterle S
- Kosterman R
- Hill KG.
- Henry KL
- Agbeke DV
- Tiberio SS
- et al.
- Substance Abuse and Mental Health Services Administration. 2018–2019 National Survey on Drug Use and Health: model-based prevalence estimates (50 states and the District of Columbia). Rockville, MD: Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2018-2019-nsduh-state-prevalence-estimates. Published December 15, 2020. Accessed December 29, 2021.View in Article
- National and state-level marijuana trends from 2002–2014. Substance Abuse and Mental Health Administration. https://www.samhsa.gov/data/nsduh/national-state-level-marijuana-trends. Accessed September 22, 2021.View in Article
- Kilmer B.
- Hall W
- Lynskey M.
- Bae H
- Kerr DCR.
